EP Biocomposites Limited has disclosed its investor presentation prepared for the upcoming annual general meeting. The filing was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The Goa-based engineering and manufacturing company reported revenue from operations of ₹1,363.98 lakh for FY26, up from ₹1,200.62 lakh in FY25. This represents a year-on-year increase of approximately 13.6%.

Financial Performance

The company’s profitability metrics showed improvement alongside top-line growth. Key financial figures for the fiscal year ending March 31, 2026 are outlined below:

Net profit for FY26 stood at ₹145.83 lakh, a significant rise from ₹103.08 lakh in the previous year. The profit after tax margin expanded to 10.69% from 8.49% in FY25.

What the Numbers Show

EBITDA grew by nearly 26% to ₹237.83 lakh in FY26, outpacing the 13.6% revenue growth. This divergence indicates operational leverage, as the EBITDA margin widened by 174 basis points to 17.43%. Finance costs remained relatively stable at ₹33.99 lakh compared to ₹35.46 lakh in FY25, suggesting controlled interest expenses despite higher operations.

Balance Sheet Position

As of March 31, 2026, total shareholders' funds increased to ₹1,205.30 lakh from ₹1,059.48 lakh in the prior year. Long-term borrowings decreased to ₹186.96 lakh from ₹245.15 lakh, indicating a reduction in long-term debt obligations. Cash and cash equivalents rose to ₹215.35 lakh from ₹161.67 lakh.

Trade receivables stood at ₹1,184.20 lakh, up from ₹1,085.68 lakh in FY25. Current liabilities totalled ₹471.19 lakh, an increase from ₹357.61 lakh in the previous fiscal year.

Business Operations

EP Biocomposites operates across three diversified verticals: Aqua (water treatment), Composites (FRP products), and Fire safety solutions. In FY26, the Aqua segment contributed the largest share of revenue at 49.45%, followed by FRP at 43.04% and Fire at 7.51%.

The company maintains a manufacturing facility in Goa with a capacity of 2.0 lakh sq. ft., operating at 70% utilization. It holds technology transfer rights from DRDO for bio-digester systems and serves government and institutional clients, which accounted for 60% of its revenue mix in FY26.

EP Biocomposites has scheduled its seventh annual general meeting for Monday, September 28, 2026. The meeting will be held at the Bicholim Industrial Estate Hall in Goa at 4:00 pm.

Shareholders will consider ordinary business items, including the adoption of audited financial statements for the fiscal year ended March 31, 2026. The board also seeks approval for the re-appointment of Mr. Rajkumar Kamat as managing director.

Key Agenda Items

The notice outlines two primary resolutions for shareholder approval:

• Adoption of the audited financial statements and reports of the Board of Directors and Auditors for FY26.
• Re-appointment of Mr. Rajkumar Kamat (DIN: 01157652), who retires by rotation and offers himself for re-election.

Voting and Logistics

The company is facilitating remote e-voting through Bigshare Services Private Limited. The voting window opens on Thursday, September 24, 2026, at 10:00 am and closes on Sunday, September 27, 2026, at 5:00 pm. Members holding shares as of the cut-off date, Wednesday, September 23, 2026, are eligible to vote.

CS Amogh Diwan has been appointed as the scrutinizer to oversee the voting process. Results will be declared immediately after the meeting and posted on the company website.